Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
2.590
+0.010 (0.39%)
May 16, 2025, 1:59 PM - Market open
Clene Employees
As of December 31, 2024, Clene had 76 total employees, including 75 full-time and 1 part-time employees. The number of employees decreased by 9 or -10.59% compared to the previous year.
Employees
76
Change (1Y)
-9
Growth (1Y)
-10.59%
Revenue / Employee
$4,605
Profits / Employee
-$382,513
Market Cap
23.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 76 | -9 | -10.59% |
| Dec 31, 2023 | 85 | -1 | -1.16% |
| Dec 31, 2022 | 86 | -16 | -15.69% |
| Dec 31, 2021 | 102 | 28 | 37.84% |
| Dec 31, 2020 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PepsiCo | 319,000 |
| Anheuser-Busch InBev | 143,885 |
| Philip Morris International | 83,100 |
| British American Tobacco p.l.c. | 74,617 |
| The Coca-Cola Company | 69,700 |
CLNN News
- 9 days ago - Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 4 weeks ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 6 weeks ago - Clene to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 7 weeks ago - Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 2 months ago - Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment - GlobeNewsWire
- 2 months ago - Clene to Present at the 37TH Annual Roth Conference - GlobeNewsWire
- 2 months ago - Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11 - Accesswire
- 2 months ago - Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction - GlobeNewsWire